These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8891165)

  • 21. Alveolar Macrophages Are a Prominent but Nonessential Target for Murine Cytomegalovirus Infecting the Lungs.
    Farrell HE; Lawler C; Oliveira MT; Davis-Poynter N; Stevenson PG
    J Virol; 2015 Dec; 90(6):2756-66. PubMed ID: 26719275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide increases the amount of murine cytomegalovirus-DNA in mice latently infected with the virus.
    Okada K; Tanaka K; Noda S; Okazaki M; Koga Y
    Arch Virol; 1999; 144(12):2273-90. PubMed ID: 10664384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfusion-transmitted cytomegalovirus (CMV) infections in a murine model: characterization of CMV-infected donor mice.
    Roback JD; Su L; Newman JL; Saakadze N; Lezhava LJ; Hillyer CD
    Transfusion; 2006 Jun; 46(6):889-95. PubMed ID: 16734804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ineffective control of murine cytomegalovirus by IE1-specific cytotoxic T lymphocytes during protracted infection in the lung.
    Chen QJ; Yoshida H; Takimoto H; Ninomiya T; Ohtsu M; Kimura G; Nomoto K
    Arch Virol; 2000; 145(7):1291-304. PubMed ID: 10963338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+ T-cell reconstitution reduces cytomegalovirus in the immunocompromised brain.
    Reuter JD; Wilson JH; Idoko KE; van den Pol AN
    J Virol; 2005 Aug; 79(15):9527-39. PubMed ID: 16014915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial.
    Finlen Copeland CA; Davis WA; Snyder LD; Banks M; Avery R; Davis RD; Palmer SM
    J Heart Lung Transplant; 2011 Sep; 30(9):990-6. PubMed ID: 21489817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of latent murine cytomegalovirus in vivo and in vitro: a pathogenetic role for acute infection.
    Jordan MC; Takagi JL; Stevens JG
    J Infect Dis; 1982 May; 145(5):699-705. PubMed ID: 6281340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Chlorella vulgaris extracts on murine cytomegalovirus infections.
    Ibusuki K; Minamishima Y
    Nat Immun Cell Growth Regul; 1990; 9(2):121-8. PubMed ID: 1693753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivation of Toxoplasma gondii by cytomegalovirus disease in mice: antimicrobial activities of macrophages.
    Pomeroy C; Kline S; Jordan MC; Filice GA
    J Infect Dis; 1989 Aug; 160(2):305-11. PubMed ID: 2547877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of biological response modifiers on chronic and latent murine cytomegalovirus infections.
    Okada M; Minamishima Y
    Microbiol Immunol; 1987; 31(5):435-47. PubMed ID: 2443815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ganciclovir on murine cytomegalovirus-induced reactivation of toxoplasma pneumonia.
    Banister S; Pomeroy C
    J Lab Clin Med; 1993 Nov; 122(5):576-80. PubMed ID: 8228576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of MDP-Lys(L18), a synthetic derivative of muramyldipeptide, on murine cytomegalovirus infection.
    Eizuru Y; Nakagawa N; Hamasuna R; Minamishima Y
    Nat Immun; 1992; 11(4):225-36. PubMed ID: 1384831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A murine model with murine cytomegalovirus infection resulting in colon inflammation after allogeneic skin transplantation].
    Zhang W; Gan L; Li RP; Chen JX; Wang ML
    Bing Du Xue Bao; 2011 Jan; 27(1):1-10. PubMed ID: 21462500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells.
    Scalzo AA; Fitzgerald NA; Wallace CR; Gibbons AE; Smart YC; Burton RC; Shellam GR
    J Immunol; 1992 Jul; 149(2):581-9. PubMed ID: 1378069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytomegalovirus infection in transplant recipients].
    Gondo H
    Nihon Rinsho; 1998 Jan; 56(1):173-8. PubMed ID: 9465685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
    Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD
    Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection.
    Shanley JD; Pesanti EL
    J Infect Dis; 1985 Mar; 151(3):454-8. PubMed ID: 2982963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus infection after liver transplantation: prophylaxis and preemptive treatment--a single-center experience.
    Perrella A; Esposito C; Ioia G; Campanella L; Taglialatela D; Cuomo O
    Transplant Proc; 2010 May; 42(4):1226-8. PubMed ID: 20534267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies.
    Farrell HE; Shellam GR
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():149-56. PubMed ID: 1846643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.